|
|
Marketing Authorisations
|
|
|
|
|
Opioid antidote nasal spray, useful and convenient in an emergency
|
|
|
|
|
|
|
|
|
|
|
|
Primarily for patients with very troublesome partial seizures
|
|
|
|
|
|
|
|
|
|
|
|
No more effective, and no safer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reviews
|
|
|
|
|
Addition of rivaroxaban to aspirin: uncertain benefits, proven harms
|
|
|
|
|
|
|
|
|
|
What is the harm-benefit balance as of 2018?
|
|
|
|
|
|
|
|
|
|
|
|
|
|